Evicita · Supplement evidence, graded and cited · Supplements · Lifestyle · Mechanisms · Lab tests · 中文

Triphala standardized extract (chebulic myrobalan, amla, belleric myrobalan)

Triphala Extract (Standardized Tannins) · also known as Triphala, Triphala, Tibetan three-fruit decoction, Chebulic, belleric and amla triple blend

Triphala is made from chebulic myrobalan, belleric myrobalan and amla, and is traditionally used for bowel regulation. Rat studies show it can shift the gut microbiota and raise markers linked to tight junctions. In a small human trial, microbiota responses varied widely between people, and an increase in short-chain fatty acids was not reported.

Typical dose: Standardized extract (40–50% tannins) at 500–1500 mg/day. There is not enough evidence that bedtime dosing on an empty stomach works better than other times; it can be taken as directed on the product label.
Absorption and forms: Triphala is rich in polyphenols and tannins. In the colon, microbial metabolism turns them into urolithin-type metabolites. How much of these metabolites forms depends on the formula’s ingredients and on the person’s gut microbiota. There is not enough evidence that taking it at bedtime on an empty stomach works better than other times.

Clinical uses and human evidence

Constipation

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Munshi 2011 · J Ayurveda Integr Med · Open-label study · n=34 — An open-label, prospective clinical study to evaluate the efficacy and safety of TLPL/AY/01/2008 in the management of functional constipation

Body weight and body fat

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Kamali 2012 · Daru · RCT · n=62 — Efficacy of 'Itrifal Saghir', a combination of three medicinal plants in the treatment of obesity; A randomized controlled trial

Blood sugar and insulin resistance

Mixed resultsGrade C · Preliminary evidence
Studies (1)
  1. Phimarn 2021 · J Evid Based Integr Med · Systematic review · n=749 — Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review

High LDL cholesterol

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Phimarn 2021 · J Evid Based Integr Med · Systematic review · n=749 — Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review
  2. Ekanayaka 2017 · Ceylon Med J · RCT · n=198 — The effect of thriphala, a herbal Ayurveda formulation, on serum lipids, in patients on a maintenance dose of atorvastatin for hyperlipidaemia: a randomized controlled trial

High triglycerides

Mixed resultsGrade C · Preliminary evidence
Studies (2)
  1. Phimarn 2021 · J Evid Based Integr Med · Systematic review · n=749 — Effects of Triphala on Lipid and Glucose Profiles and Anthropometric Parameters: A Systematic Review
  2. Ekanayaka 2017 · Ceylon Med J · RCT · n=198 — The effect of thriphala, a herbal Ayurveda formulation, on serum lipids, in patients on a maintenance dose of atorvastatin for hyperlipidaemia: a randomized controlled trial

Mechanisms of action

Colonic short-chain fatty acid (SCFA/butyrate) fermentation substrate and receptor activation

★★★☆☆Mechanism evidence: grade CSecondary target

In an oral dosing study in rats, Triphala changed the gut microbiota and increased markers related to short-chain fatty acids. But a shift in microbial composition does not equal butyrate production. A small randomized human trial also did not report an increase in short-chain fatty acids, and not all clostridia are harmful.

References (2)
  1. Peterson 2020 · Small human RCT: the microbiota response to 2 g/day was highly individual, and an increase in short-chain fatty acids was not reported.
  2. Jiang 2024 · Oral study in rats: Triphala changed the gut microbiota and increased short-chain fatty acid-related markers.

Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair

★★★☆☆Mechanism evidence: grade CSecondary target

In an oral dosing study in rats, Triphala raised intestinal ZO-1 and claudin-1 expression and improved permeability-related markers. A protective film formed by tannins and mucosal proteins is not the same as repair of tight junctions, and improvement in human “leaky gut” has not been confirmed.

References (1)
  1. Jiang 2024 · Oral study in rats: intestinal ZO-1 and claudin-1 expression increased, and permeability-related markers improved.

Direct free radical trapping and chemical quenching

★☆☆☆☆Mechanism evidence: grade DSecondary target

In-vitro studies show that Triphala and its components react with free radicals and have antioxidant activity, and the polyphenol components can scavenge free radicals. This does not show a direct systemic scavenging effect after oral intake. Absorption and microbial metabolism also vary markedly between people.

References (1)
  1. Naik 2005 · In-vitro study: Triphala and its components have free-radical reactivity and antioxidant activity.

Safety and drug interactions

Use with caution in pregnancy (traditionally considered to have mild qi-descending and blood-moving effects). Pause during an acute episode of diarrhea. Long-term or high-dose use may lead to laxative dependence. A risk of dependence or melanosis coli cannot currently be ruled out, so watch for changes in bowel habits during continuous use.
Open in the interactive app ›